NRx Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Business Update
Over the past 12 months, the Company reinitiated its psychiatry development program post pandemic, transferred manufacturing of NRX-101 to the US, and...
Stay updated with breaking news from Expanded Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Over the past 12 months, the Company reinitiated its psychiatry development program post pandemic, transferred manufacturing of NRX-101 to the US, and...
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage CNS biopharmaceutical company, today reported...
EQS-News: Heidelberg Pharma AG / Key word: Annual Report Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business 24.03.2023 / 07:11... | March 24, 2023
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to...
/PRNewswire/ -- BioVentrix®, Inc., a privately held medical device company developing less invasive therapies to directly treat the dilated left ventricle...